Phase II-III CRO Benchmarking—Small Pharma Market (5th Ed.)
![Phase II-III CRO Benchmarking—Small Pharma Market (5th Ed.)](https://isrreports.com/wp-content/uploads/2024/06/preview-image-2024-Phase-II-III-CRO-Benchmarking-Small-Pharma-1024x632.png)
Report Overview: ISR understands the desire for a deeper dive regarding the small and emerging biopharma landscape. The needs, practices, and perceptions of outsourcers at small and emerging sponsor organizations are not necessarily the same compared to the wider audience…